西藏奇正藏药股份有限公司 可转债交易异常波动公告

Group 1 - The company issued convertible bonds totaling 800 million RMB with a face value of 100 RMB each, approved by the China Securities Regulatory Commission on September 22, 2020 [1][2] - The bonds were listed on the Shenzhen Stock Exchange on October 27, 2020, under the name "奇正转债" and code "128133" [2] - The conversion period for the bonds starts from March 29, 2021, and ends on September 21, 2026 [3] Group 2 - The conversion price of the bonds has been adjusted multiple times, starting from 30.12 RMB/share to 29.78 RMB/share on July 8, 2021, and further adjustments down to 19.01 RMB/share by July 10, 2025 [4][5][6][7] - The company experienced a significant trading fluctuation, with the bond price deviating by over 30% during three consecutive trading days in late July 2025 [8] Group 3 - The company confirmed that there were no undisclosed significant matters affecting the bond's trading price and that its operational status remains normal [8][9] - As of August 1, 2025, the closing price of the bonds was 197.00 RMB, representing a premium of 97.00% over the face value, with a conversion value of 182.4829 RMB and a conversion premium rate of 7.96% [8]